cardiovascular risk management in dyslipidemia: clinical controversies
DESCRIPTION
Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies. Statin Intolerance. PROVE-IT TIMI 22. Familial Hypercholesterolemia. Estimated Rates of FH Diagnoses. LDL Hypothesis. Impact of PCSK9 on LDL Receptor Expression. PCSK9 Inhibitors. Abbreviations. Abbreviations (cont). - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/1.jpg)
Cardiovascular Risk Management in Dyslipidemia: Clinical
Controversies
![Page 2: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/2.jpg)
Statin Intolerance
![Page 3: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/3.jpg)
PROVE-IT TIMI 22
![Page 4: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/4.jpg)
Familial Hypercholesterolemia
![Page 5: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/5.jpg)
Estimated Rates of FH Diagnoses
![Page 6: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/6.jpg)
LDL Hypothesis
![Page 7: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/7.jpg)
Impact of PCSK9 on LDL Receptor Expression
![Page 8: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/8.jpg)
PCSK9 Inhibitors
![Page 9: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/9.jpg)
![Page 10: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/10.jpg)
![Page 11: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/11.jpg)
![Page 12: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/12.jpg)
![Page 13: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/13.jpg)
![Page 14: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/14.jpg)
![Page 15: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/15.jpg)
![Page 16: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/16.jpg)
Abbreviations
![Page 17: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/17.jpg)
Abbreviations (cont)
![Page 18: Cardiovascular Risk Management in Dyslipidemia: Clinical Controversies](https://reader036.vdocuments.net/reader036/viewer/2022062305/56815f11550346895dcdd2e7/html5/thumbnails/18.jpg)
References